JonathanDayMDPharmD

Internal Medicine • Rochester, MN

Hematology/Oncology

Fellow Physician

Join to view full profile

Dr. Day is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Day's full profile

Already have an account?

Office
200 1st St SW
Rochester, MN 55905
Phone+1 507-284-2511

Education & Training

Mayo ClinicResidency, 2027
University of Iowa Hospitals and ClinicsResidency, Internal Medicine, 2020 - 2024
Southern Illinois University School of MedicineClass of 2020
St. Louis College of PharmacyPharmD, Magna Cum Laude, 2008 - 2014

Certifications & Licensure

MN State Medical License 2024 - 2025
IA State Medical License 2020 - 2024

Awards, Honors, & Recognition

François M. Abboud Resident Research Award University of Iowa Department of Internal Medicine, 2023
Graduate Medical Education Excellence in Clinical Teaching Award University of Iowa GME, 2021-2023

Publications & Presentations

PubMed

Optimizing Utilization of SGLT2 Inhibitors in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease in a VA Primary Care Clinic: An Interdisciplinary Quali...
Solanus de la Serna, Sruti Prathivadhi-Bhayankaram, Rachel Anderson, Arya Zandvakili, Jonathan Day
American Journal of Medical Quality. 2024-07-26
3 citations
Associated comorbidities, healthcare utilization & mortality in hospitalized patients with haemophilia in the United States: Contemporary nationally representative est...
Jonathan R Day, Clifford Takemoto, Anjali Sharathkumar, Sarah Makhani, Ashwin Gupta
Haemophilia. 2022-07-01
Perspectives on Follicular Lymphoma Treatment From New and Experienced Clinicians: New, Old, & Old Is New
Jonathan R Day, Brian K Link
Oncology. 2022-02-08

Books/Book Chapters

Handbook of Hematologic Malignancies
Chapter: Therapeutic Apheresis Indications
Page 451 - 456Vasovic LV, Day JR, Goel REditors: Sallman DA, Chaudhury A, Nguyen J, Zhang L.Springer Publishing , New York Edition 2nd,2020
Handbook of Hematologic Malignancies
Chapter: Thrombotic Microangiopathy
Page 441 - 450Day JR, Vasovic LV, Goel REditors: Sallman DA, Chaudhury A, Nguyen J, Zhang L.Springer publishing, New York Edition 2nd,2020

Abstracts/Posters

Outcomes and Prognostic Factors of Transformed Follicular Lymphoma: An Analysis from the LEO Consortium
Jonathan R Day, Melissa C. Larson, Carla Casulo, Yucai Wang, Dai Chihara, Brad S. Kahl, Peter Martin, Izidore S. Lossos, Victor M. Orellana-Noia, Richard Burack, Jonat..., ASH 2022, New Orleans, LA; Blood (2022) 140 (Supplement 1): 6642–6644., 12/10/2022
Favorable Overall Survival Following First and Second Relapse of MCL with Availability of Novel Therapies: Results from the Lion Prospective Observational Registry
David A. Bond, Jason T. Romancik, Jeffrey M. Switchenko, Brielle Berkowitz, Jonathan R Day, Umar Farooq, Sabarish Ayyappan, Katelin Baird, Michelle L. Churchman, Andre..., ASH 2022;, Blood (2022) 140 (Supplement 1): 6509–6511., 12/10/2022
Therapy for patients with POD24 follicular lymphoma: Treatment patterns and outcomes from the Lymphoma Epidemiology of Outcomes (LEO) Consortium.
Casulo C, Larson MC, Day JR, Habermann TM, Lossos IS, Wang Y, Nastoupil LJ, Strouse C, Chihara D, Martin P, Cohen JB, Kahl BS, Burack WR, Koff JL, Friedberg JW, Cerhan..., Journal of Clinical Oncology / ASCO, Chicago, IL, 6/4/2022
Quality of Life Outcomes in Sarcoma Patients Receiving Care at a Tertiary Center
Day JR, Miller B, Mott SL, Loeffler BT, Tanas M, Curry M, Davick J, Milhem MM, Monga V, Journal of Clinical Oncology, 5/28/2021
Risk Factors and Cardiovascular Disease (CVD) Related Outcomes in Hospitalized Patients with Hemophilia 10 Year Follow up
Day JR, Gupta A, Abro C, Jung K, Krishnamurti L, Takemoto C, Goel R, ASH 2020 / Blood, San Diego, 12/7/2020
Join now to see all